ESC Professional Premium Access

COVID-19 and cardiovascular disease in special populations

Event: ESC Congress 2022
Topic: Cardiovascular Disease in Special Populations
Session type: Moderated ePosters
Date: 29 August 2022
Time: 10:15 - 11:00

Congress Session

6 presentations in this session

COVID-19 vaccine-induced myocarditis vs. Immune checkpoint inhibitor-induced myocarditis - Same but different?

Speaker: Doctor M. Laufer-Perl (Tel Aviv, IL)
Thumbnail

Impaired endothelial glycocalyx, vascular dysfunction and myocardial deformation four months after COVID-19 infection are partially improved at twelve months.

Speaker: Doctor I. Ikonomidis (Athens, GR)
Thumbnail

Predictors and clinical consequences of heart damage in CMR in patients after COVID-19

Speaker: Doctor M. Chudzik (Lodz, PL)
Thumbnail

Parameters of coagulation and platelet hyperreactivity reflect an increased mortality in patients with moderate to severe COVID-19

Speaker: Mr K. Jakobs (Berlin, DE)
Thumbnail

Galectin-3 as a possible marker for increased thrombogenicity in COVID-19

Speaker: Ms M. Puccini (Berlin, DE)
Thumbnail

Pragmatic observations from a post-Covid-19 cardiac evaluation register: prevalence of cardiological alterations from a basic diagnostic sequence and contribution of the clinical hystory.

Speaker: Doctor G. Ruiz (Buenos Aires, AR)
Thumbnail

6 speakers from this session

Doctor Michal Laufer-Perl

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)
0 follower

Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)
5 presentations
3 followers

Doctor Michal Chudzik

Medical University of Lodz, Lodz (Poland)
0 follower

Mr Kai Jakobs

Charite University Hospital, Berlin (Germany)
1 presentation
0 follower

Ms Marianna Puccini

Charite University Hospital, Berlin (Germany)
0 follower

Doctor Graciela Aurora Ruiz

Hospital Fernandez, Buenos Aires (Argentina)
0 follower

This platform is supported by

logo Novo Nordisk